The Normative Cost of Twenty Most Prominent Diseases in Yogyakarta, Indonesia: A Delphi Consensus Study
Penulis/Author
INDRIYATI HADI S (1); Prof. Dr. Susi Ari Kristina, S.Farm., M.Kes., Apt. (2); Prof. dr. Ali Ghufron Mukti, M.Sc., Ph.D. (3); Prof. Dr. Satibi, S.Si., M.Si. Apt. (4)
Tanggal/Date
2022
Kata Kunci/Keyword
Abstrak/Abstract
Objective: To formulate a convergent and consensus expert panel to calculate normative drug
cost in the top twenty diseasesin primary care. Method: In the first round, the expert panel define
a list of consensus statements based on data derived from non-systematic reviews of treatment
standard for the top twenty disease in primary care. In the second round, experienced doctors
in treatment at primary care were involved to express individual consent to the statements
using questionnaire. Face-to-face meeting were held simultaneously with filling questionnaire.
Consensus was defined as 75% agreement. Result: Delphi process at the first round, the expert
panel consisting of 11 doctors in primary care defined a list of 60 statements from 20 diseases
on the treatment standard calculated the normative cost of acute and chronic disease in primary
care. The second round involved 11 doctors who are experienced in primary care with more than
6 years’ experience in doing treatment in primary care. Conclusion: The identified consensus
statement can help doctors to apply the normative cost calculation results on the top 20 diseases
in primary care as evidence based policy study material for calculating the percentage of drug
cost in the capitation system in Indonesia.
